Roger Garceau - Jun 12, 2025 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
Director
Signature
/s/ Mary Grendell, Attorney-in-fact
Stock symbol
TARA
Transactions as of
Jun 12, 2025
Transactions value $
$0
Form type
4
Date filed
6/13/2025, 04:05 PM
Previous filing
Jun 10, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GARCEAU ROGER Director C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK /s/ Mary Grendell, Attorney-in-fact 2025-06-13 0001451767

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TARA Stock Option (Right to Buy) Award $0 +24K $0.00 24K Jun 12, 2025 Common Stock 24K $3.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control.